Skip to main content

Part of the book series: Prostaglandins, Leukotrienes, and Cancer ((PLAC,volume 1))

Abstract

Nearly all higher eukaryotic cells have the capacity for active cell movement. Active movement occurs in a variety of normal biological processes and in several pathological conditions. Examples include fertilization, embryonic development, inflammation, wound healing and tumor cell invasion & metastasis. The involvement of cell motility in these complex biological processes insures that cell movement will not occur in an unregulated manner. Rather, the movement of cells in multicellular organisms in closely controlled. A number of different mechanisms appear to be involved. In addition to factors which turn cell movement “on” and “off”, there are factors which influence the direction in which cell movement occurs. Contact inhibition, contact guidance, haptotaxis and Chemotaxis are all terms that describe the regulation of directional cell movement.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 169.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 219.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Snyderman R, Goetzl EJ: Molecular and cellular mechanisms of leukocyte Chemotaxis. Science (213):830–836, 1981.

    Article  PubMed  CAS  Google Scholar 

  2. Keller HU, Till GO: Leukocyte Locomotion and Chemotaxis. Birkhauser Verlag, Basel 1983.

    Google Scholar 

  3. Wilkinson PC: Chemotaxis and Inflammation. 2nd edition. Churchill Livingstone New York, 1982.

    Google Scholar 

  4. Varani J, Orr FW: Chemotaxis in non-leukocytic cells. In: Ward PA (ed). Handbook of Inflammation Vol. 4 Elsevier, Amsterdam, 1983, pp 211–244.

    Google Scholar 

  5. Kreutzer DL, O’Flaherty JT, Orr W, Showell HJ, Ward PA, Becker EL: Quantitative comparisons of various biological responses of neutrophils to different active and inactive chemotactic factors. Immunopharmacology (1):39–47, 1978.

    Article  PubMed  CAS  Google Scholar 

  6. Simchowitz L, Mehta J, Spilberg I: Chemotactic factor-induced superoxide radical generation by human neutrophils: Requirement for protease (esterase) activity. J. Lab. Clin. Med. (94):403–407, 1979.

    PubMed  CAS  Google Scholar 

  7. Dunn GA: Mechanisms of fibroblast locomotion. In: Gurtis ASJ and Pitts JD (eds) Cell Adhesion and Motility. Cambridge University Press, New York, 1980. pp 409–424.

    Google Scholar 

  8. Stossel TP: The mechanism of leukocyte locomotion. In: Gall JI and Quie PG (eds). Leukocyte Chemotaxis: Methods, Physiology and Clinical Implications. Raven Press, New York, pp 143–157.

    Google Scholar 

  9. Vitkauskas GG, Showell HJ, Becker EL: Specific binding of synthetic chemotactic peptides to rabbit peritoneal neutrophils: Effects of dissociability of bound peptide, receptor activity and subsequent biological responsiveness (deactivation) Mol. Immunol. (17): 171–179, 1980.

    CAS  Google Scholar 

  10. Chiang TM, Postlethwaite AE, Beachey EH, Seyer JM and Kang AH: Binding of chemotactic collagen-derived peptides to fibroblasts: The relationship to fibroblast Chemotaxis. J. Clin. Invest. (62):916–922, 1978.

    Article  PubMed  CAS  Google Scholar 

  11. Clarke PRH, Varani J: Phorbol ester binding to chemotacticallyresponsive and non-responsive Walker 256 carcinosarcoma cells. Cancer Res. (in press).

    Google Scholar 

  12. Rao KMK, Varani J: Actin polymerization induced by chemotactic peptide and concanavalin A in rat neutrophils. J. Immunol. (129): 1605–1607, 1982.

    PubMed  CAS  Google Scholar 

  13. Malech HL, Root RK, Gall in JI: Structural analysis of human neutrophil migration: Centriole, microtubule and microfilament orientation and function during Chemotaxis. J. Cell Biol. (75):666–670, 1977.

    Article  PubMed  CAS  Google Scholar 

  14. Zigmond SH: Ability of polymorphonuclear leukocytes to orient in gradients of chemotactic factors. J. Cell Biol. (75):606–616, 1977.

    Article  PubMed  CAS  Google Scholar 

  15. Marasco WA, Becker EL, Oliver JM: The ionic basis of Chemotaxis: Separate cation requirements for neutrophil orientation and locomotion in a gradient of chemotactic peptide. Am. J. Path. (98):749–768, 1980.

    PubMed  CAS  Google Scholar 

  16. Kuehl FA, Egan RW: Prostaglandins, arachidonic acid and inflammation. Science (210):978–984, 1980.

    Article  PubMed  CAS  Google Scholar 

  17. O’Flaherty JT: Lipid mediators of inflammation and allergy. Lab. Invest. (47):314–329, 1982.

    Google Scholar 

  18. Hirata F, Corcoran BA, Venkatasubramanain K, Schiffmann E, Axelrod J: Chemoattractants stimulate degradation of methylated phospholipids and release of arachidonic acid in rabbit leukocytes. Proc. Nat. Acad. Sci. USA (76):2640–2643, 1979.

    Article  PubMed  CAS  Google Scholar 

  19. Hirata F, Axelrod J: Phospholipid methylation and biological signal transmission. Science (209):1082–1090, 1980.

    Article  PubMed  CAS  Google Scholar 

  20. Michel RH: Inositol phospholipids and cell surface receptor function. Biochim. Biophys. Acta. (415):81–147, 1975.

    Google Scholar 

  21. Lapetina EG, Billah MM, Cuatrecasas P: Rapid acylation and deacylation of arachidonic acid into phosphatidic acid of horse neutrophils. J. Biol. Chem. (225):10966–10970.

    Google Scholar 

  22. Kroner EE, Peskar BA, Fischer H, Ferber E: Control of arachidonic acid accumulation in bone marrow-derived macrophages by acyltransferases. J. Biol. Chem. (256):3690–3697, 1981.

    PubMed  CAS  Google Scholar 

  23. Samuelsson B: Oxidative products of arachidonate: Leukotrienes, a new group of compounds including SRS-A. In: Becker EL, Simon AS and Austen KF (eds) Biochemistry of the Acute Allergic Reaction, Fourth International Symposium Alan R Liss, Inc. New York, 1980. pp 1–12.

    Google Scholar 

  24. Samuelsson B: The leukotrienes: A new group of biologically-active compounds including SRS-A. Trends Pharmacol. Sci. (1):227–230, 1980.

    Article  CAS  Google Scholar 

  25. Morley J, Bray MA, Jones RW, Nugteren DH, Van Dorp DA: Prostaglandin and thromboxane production by human and guinea pig macrophages and leukocytes. Prostaglandins (17):729–736, 1979.

    Article  PubMed  CAS  Google Scholar 

  26. Smith MJH: Prostaglandins and the polymorphonuclear leukocyte. In: Ford-Hutchinson AW and Rainsford KD (eds) Prostaglandins and Inflammation Birkhauser Verlag, Basel, 1980, pp 91–103.

    Google Scholar 

  27. Goetzl EJ, Woods JM, Gorman RR: Stimulation of human eosinophil and neutrophil polymorphonuclear leukocyte Chemotaxis and random migration by 12-L-hydroxy-5,8,10,14-eicosatetraenoic acid. J. Clin. Invest. (59):179–183, 1977.

    Article  PubMed  CAS  Google Scholar 

  28. Goetzl EJ, Pickett WC: The human PMN leukocyte chemotactic activity of complex hydroxy-eicosatetraenoic acids (HETEs). J. Immunol. (125):1789–1791, 1980.

    PubMed  CAS  Google Scholar 

  29. Goetzl EJ, Brash AR, Tauber AI, Oates JA, Hubbard WC: Modulation of human neutrophil function by monohydroxy-eicosatetraenoic acids. Immunology (39):491–501, 1980.

    PubMed  CAS  Google Scholar 

  30. Ford-Hutchinson AW, Bray MA, Doig MV, Shipley ME, Smith MJH: Leukotriene B, a potent chemokinetic and aggregating substance released from polymorphonuclear leukocytes. Nature (286):264–265, 1980.

    Article  PubMed  CAS  Google Scholar 

  31. O’Flaherty JT, Thomas MJ, Lees CJ, McCall CE: Neutrophil-aggregating activity of monohydroxyeicosatetraenoic acids. Am. J. Path. (104):55–62, 1981.

    PubMed  Google Scholar 

  32. Goetz EJ, Weller PE, Sun FF: The regulation of eosinophil function by endogenous mono-hydroxy-eicosatetraenoic acids (HETEs). J. Immunol. (124):926–933, 1980.

    Google Scholar 

  33. Showell HJ, Naccache PH, Sha’afi RI, Becker EL: Inhibition of rabbit neutrophil lysozomal enzyme secretion, non-stimulated and chemotactic factor stimulated locomotion by nordihydroguaiaretic acid. Life Sciences (27):421–426, 1980.

    Article  PubMed  CAS  Google Scholar 

  34. Smolen JE, Weissmann G: Effects of indomethacin, 5,8,11,14-eicosatetrynoic acid and p-bromophenacyl bromide on lysozomal enzyme release and superoxide anion generation by human polymorphonuclear leukocytes. Brit. J. Pharmacol. (29):533–538, 1980.

    CAS  Google Scholar 

  35. Goetzl EJ, Hill HR, Gorman RR: Unique aspects of the modultion of human neutrophil function by 12-L-hydroperoxy-5,8,10,14-eicosatetraenoic acid. Prostaglandins (19):71–85, 1980.

    Article  PubMed  CAS  Google Scholar 

  36. Stenson WF, Parker CW: Metabolism of arachidonic acid in ionophore-stimulated neutrophils: Esterification of a hydroxylated metabolite into phospholipids. J. Clin. Invest. (64):1457–1465, 1979.

    Article  PubMed  CAS  Google Scholar 

  37. Goldman DW, Goetzl EJ. Novel metabolites of arachidonic acid in human neutrophils. Fed. Proc. (40):1004a, 1981.

    Google Scholar 

  38. Mensing H, Czarnetski BM: Leukotriene B, induced in vitro fibroblast Chemotaxis. J. Invest. Derm. (82):9–12, 1984.

    Article  PubMed  CAS  Google Scholar 

  39. Varani J, Fantone JC: Phorbol myristate acetate-induced adherence of Walker 256 carcinosarcoma cells. Cancer Res. (42):190–197, 1982.

    PubMed  CAS  Google Scholar 

  40. Varani J: Chemotaxis of metastatic tumor cells. Cancer Mets. Reviews (1):17–28, 1982.

    Article  CAS  Google Scholar 

  41. Chensue SW, Kunkel SL, Higashi 61, Ward PA, Boros DL: Production of superoxide anion, prostaglandins, and hydroxyeicosatetraenoic acids by macrophages from hypersensitivity — type (Schistosoma mansoni egg) and foreign body — type granulomas. Infect. Immun. (42):1116–1125, 1983.

    PubMed  CAS  Google Scholar 

  42. Rivkin I, Rosenblatt J, Becker EL: The role of cyclic AMP in the chemotactic responsiveness and spontaneous motility of rabbit peritoneal neutrophils. The inhibition of neutrophil movement and the elevation of cyclic AMP levels by catecholamines, prostaglandins, theophilline and cholera toxin. J. Immunol. (115): 1126–1134, 1975.

    PubMed  CAS  Google Scholar 

  43. OFlaherty JT, Kreutzer DL, Ward PA: Effect of prostaglandin E1, E2 and F on neutrophil aggregation. Prostaglandins (17):201–210, 1979.

    Article  CAS  Google Scholar 

  44. Kbftkel SL, Thrall RS, Kunkel RG, McCormick JR, Ward PA, Zurier RB: Suppression of immune complex vasculitis in rats by prostaglandins. J. Clin. Invest. (64): 1525–1529, 1979.

    Article  Google Scholar 

  45. Kunkel SL, Chensue SW, Plewa M, Higashi GI: Macrophage function in the Schistosoma mansoni egg-induced pulmonary granuloma: Role of arachidonic acid metabolites in macrophage la antigen expression. Am. J. Path. (114):240–249, 1984.

    PubMed  CAS  Google Scholar 

  46. Fantone JC, Marasco WA, El gas LJ, Ward PA: Anti-inflammatory effects of prostaglandin E1: In vivo modulation of the formyl peptide chemotactic receptor on the rat neutrophil. J. Immunol. (130):1495–1497, 1983.

    PubMed  CAS  Google Scholar 

  47. Fantone JC, El gas LJ, Weinberger L, Varani J: Modulation of tumor cell adherence by prostaglandins. Oncology (40):421–426, 1983.

    Article  PubMed  CAS  Google Scholar 

  48. Fantone JC, Kunkel SL, Varani J: Inhibition of tumor cell adherence by prostaglandins. In: Mundy GR (ed) Prostaglandins and Cancer; First International Conference. Alan R. Liss, Inc. New York 1982, pp 673–677.

    Google Scholar 

  49. Lee EC, Situ R, Fantone JC, Varani J: Functional responses of tumor cells to phorbol esters: Role for prostaglandins. Oncology (in press).

    Google Scholar 

  50. Grimstad IA, Wass JA, Spirnak J, Fantone JC, Varani J: Chemotactic factor-induced adherence of tumor cells. Invasion Metastasis (2):274288, 1982.

    Google Scholar 

  51. Orr FW, Varani J, Delikatny J, Jain N, Ward PA: Comparison of the chemotactic responsiveness of fibrosarcoma subpopulations of differing malignancy. Am. J. Path. (102): 160–167, 1981.

    PubMed  CAS  Google Scholar 

  52. Laskin D, Laskin JD, Weinstein B, Carchman RA: Induction of Chemotaxis in mouse peritoneal macrophages by phorbol ester tumor promoters. Cancer Res. (41):1923–1928, 1981.

    PubMed  CAS  Google Scholar 

  53. Fitzpatrick FA, Bundy GL: Hapten mimic elicits antibodies recognizing prostaglandin E2. Proc. Nat. Acad. Sci. USA (75):2689–2693, 1978.

    Article  PubMed  CAS  Google Scholar 

  54. Fitzpatrick FA, Wynalda MA: A rapid, solid-phase radioimmunoassay for prostaglandin F and its main circulating metabolites. Analyt. Biochem. (73):198–208, 1976.

    Article  PubMed  Google Scholar 

  55. Fitzpatrick FA, Gorman RR, McGuire JC, Kelly RC, Wynalda MA, Sun FF: A radioimmunoassay for thromboxane B2. Analyt. Biochem. (82):1–7, 1977.

    CAS  Google Scholar 

  56. Honn KV, Cicone B, Skoff A: Prostacyclin: A potent antimetastatic agent. Science (212): 1270–1272, 1981.

    Article  PubMed  CAS  Google Scholar 

Download references

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1985 Martinus Nijhoff Publishing, Boston

About this chapter

Cite this chapter

Varani, J. (1985). Chemotaxis. In: Lands, W.E.M. (eds) Biochemistry of Arachidonic Acid Metabolism. Prostaglandins, Leukotrienes, and Cancer, vol 1. Springer, Boston, MA. https://doi.org/10.1007/978-1-4613-2597-0_14

Download citation

  • DOI: https://doi.org/10.1007/978-1-4613-2597-0_14

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-1-4612-9627-0

  • Online ISBN: 978-1-4613-2597-0

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics